skip to main content

Maternal TRAb – neonatal risk — RACP Paediatrics MCQ

Instant feedback + full explanation. One question, done properly.

ModerateEndocrineMaternal TRAb – neonatal riskRACP Paediatrics

A pregnant woman with current Graves disease has high TRAb levels at 36 weeks. What investigation should be planned for the neonate?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CMaternal Graves disease – check TRAb

Maternal TRAb levels should be checked in the third trimester in all pregnant women with current or past Graves disease. High TRAb levels (>3× upper limit of normal) indicate risk of neonatal thyrotoxicosis. The neonate should have TFTs checked at day 3-5 (delayed presentation is possible if maternal carbimazole was masking fetal thyrotoxicosis). Neonatal monitoring for thyrotoxicosis should continue for 2-3 months.

Reference: RCH Melbourne – 2023 – Neonatal Thyroid CPG; RACP Paediatric Curriculum – Endocrine